Pharmacologic treatment of epilepsy (Q30450665)

21 June 2017

title

Pharmacologic treatment of epilepsy (English)

1 reference

21 June 2017

Nathan B Fountain

1

1 reference

21 June 2017

Andrew J Cole

series ordinal

2

1 reference

21 June 2017

publication date

1 March 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

15

1 reference

21 June 2017

issue

3 Suppl 5

1 reference

21 June 2017

page(s)

4-6

1 reference

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Levetiracetam monotherapy for late poststroke seizures in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Zonisamide for weight loss in obese adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900027632

7 January 2021

10.1017/S1092852900027632

Identifiers

DOI

0 references

1 reference